Navigation Links
MRIGlobal, DHMRI Align in Strategic Collaboration
Date:7/11/2012

KANSAS CITY, Mo., July 11, 2012 /PRNewswire-USNewswire/ -- MRIGlobal today announced a joint marketing and business development agreement with the David H. Murdock Research Institute, a leading not-for-profit biotechnology research organization.

The agreement leverages research and development resources of both organizations to address challenges in food safety and biosurveillance.

"This agreement gives both organizations the opportunity to align resources to better tackle the challenges of monitoring the food supply chain and assuring safe, healthy products for consumers," said Robert Casillas, Ph.D., Vice President Strategic Life Sciences and National Security for MRIGlobal.

"We are excited to work with MRIGlobal to address these challenges. The depth of experience at both organizations enables us to provide benefits to both companies and consumers," said Steve Lommel, Ph.D., Interim President, David H. Murdock Research Institute. 

The David H. Murdock Research Institute, located in Kannapolis, N.C., focuses on research and development in agriculture, nutrition and human health.

MRIGlobal recently formed a new operating unit, Global Health and Security, which focuses on Biosurveillance and Food Safety as well as Medical Countermeasures, Diagnostics, and Drug Development and Repository Management.

About MRIGlobal
MRIGlobal, a not-for-profit research and development organization, delivers global solutions in national security and defense, energy and environment, life and animal sciences, agriculture and food safety, and transportation. The organization performs scientific research, advanced engineering and program integration and management for clients in government, industry and academia.  Established in 1944 as Midwest Research Institute, MRIGlobal is based in Kansas City, Mo., operates in nine states and Washington, D.C., and manages more than 3,300 employees.

MRIGlobal is one of two partners in the Alliance for Sustainable Energy, LLC, which manages and operates the National Renewable Energy Laboratory (NREL) in Golden, Colo., for the U.S. Department of Energy. For more information, visit www.mriglobal.org.

About the David H. Murdock Research Institute
The David H. Murdock Research Institute (DHMRI) is a non-profit, contract research organization committed to the improvement of human life. DHMRI provides collaborators groundbreaking research and development solutions at the intersection of human health, agriculture and nutrition. From the largest corporations, to life science start-ups and academic researchers, DHMRI combines collaboration and customized solutions to find the answers to advance research and product development. To learn more, visit www.dhmri.org.


'/>"/>
SOURCE MRIGlobal
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. How Malignant Cells in Patients With Chronic Lymphocytic Leukemia Escape T Cell Recognition and Attack
2. WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment
3. Karyopharm Therapeutics Announces Multiple Presentations on Selective Inhibitors of Nuclear Export (SINE) in Solid and Hematologic Malignancy Models and Spontaneous Canine Cancers at the American Association of Cancer Research (AACR) Meeting
4. Big Pharma and Universities Increasingly Work to Advance Life Science Knowledge by Forming Strategic Partnerships, Public-Private Partnerships, and Open Innovation Programs: Pharmaceutical Research Collaborations Summit
5. Daiichi Sankyo And Coherus BioSciences Establish Strategic Collaboration To Develop And Commercialize Biosimilar Candidates
6. Genomic Health and OncoMed Announce Strategic Alliance for Biomarker Research and Discovery Using Next Generation Sequencing
7. Psyche Systems Corporation Signs Strategic Alliance with Siemens Healthcare to Provide Anatomic Pathology Solutions
8. BioRestorative Therapies Retains KCSA Strategic Communications as Investor Relations Counsel
9. Chemring Detection Systems Awarded $500k for Strategic Research and Development
10. SiREM and Tersus Environmental Form Strategic Marketing Alliance
11. Strategic Analysis of the Collagen Peptide Market in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , ... December 01, 2016 , ... ... long-term client Nanowear on their recent FDA Class II 510(k) clearance for their ... significant hurdle in commercializing remote cardiac monitoring devices that rely on cloth-based nanosensors. ...
(Date:12/2/2016)... bioLytical Laboratories, a world leader in rapid infectious disease tests, introduced the Company,s newest ... members. (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) Continue Reading ... ... , , bioLytical was invited ... introduce the INSTI HIV Self Test to 350 pharmacy representatives in Nairobi ...
(Date:11/30/2016)... Nov. 30, 2016 Biotest Pharmaceuticals Corporation (BPC), ... to announce the addition of its newest plasma collection ... Nebraska . The 15,200 square foot state-of-the-art facility ... 2016 and brings the total number of BPC,s plasma ... Carlisle , BPC,s Chief Executive Officer said "We are ...
(Date:11/30/2016)... November 2016   Merck , ein ... Unterzeichnung einer Reihe von Vereinbarungen mit Evotec ... AG Screeningleistungen für Mercks Palette genetischer Reagenzien ... auf diese Bibliotheken in Kombination mit Evotecs ... Weg zur Ermittlung und Erforschung neuer Arzneimitteltargets.    ...
Breaking Biology Technology:
(Date:11/29/2016)... CANNES, France , November 29, 2016 Nearly ... Continue Reading ... ... System is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric ...
(Date:11/21/2016)... Nov. 21, 2016   Neurotechnology , a ... technologies, today announced that the MegaMatcher On Card ... submitted for the NIST Minutiae Interoperability Exchange ... the mandatory steps of the evaluation protocol. ... continuing test of fingerprint templates used to establish ...
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
Breaking Biology News(10 mins):